Cleared Special

K141423 - NASOPORE-FD

K141423 is an FDA 510(k) clearance for NASOPORE-FD, manufactured by Polyganics B.V.,. The device is a Class 1 Ear, Nose, Throat device with product code LYA cleared through the Special 510(k) pathway after a 69-day FDA review.

K141423 · Polyganics B.V., · Ear, Nose, Throat device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2014
Decision
69d
Days
Class 1
Risk

K141423 is an FDA 510(k) clearance for the NASOPORE-FD. Classified as Splint, Intranasal Septal (product code LYA), Class I - General Controls.

Submitted by Polyganics B.V., (Groningen, NL). The FDA issued a Cleared decision on August 7, 2014 after a review of 69 days - a notably fast clearance cycle.

This device falls under the Ear, Nose, Throat FDA review panel, regulated under 21 CFR 874.4780 - the FDA ear, nose and throat device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Polyganics B.V., devices

FDA 510(k) Submission Details - K141423

510(k) Number K141423 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 30, 2014
Decision Date August 07, 2014
Days to Decision 69 days
Submission Type Special
Review Panel Ear, Nose, Throat (EN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
21d faster than avg
Panel avg: 90d · This submission: 69d
Pathway characteristics
Modification to existing cleared device.

LYA Device Classification - Class 1, General Controls

Product Code LYA Splint, Intranasal Septal
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 874.4780
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - LYA Splint, Intranasal Septal

All 37
Devices cleared under the same product code (LYA) and FDA review panel - the closest regulatory comparables to K141423.
SPIWay Endonasal Access Guide
K153686 · Spiway, LLC · Jan 2016
HEMOPORE
K141816 · Polyganics B.V., · Oct 2014
NOVASHIELD INJECTABLE NASAL PACKING AND STENT
K141704 · Medtronic, Inc. · Oct 2014
ARTHROCARE NASASTENT CMC NASAL DRESSING
K140992 · ArthroCare Corporation · Jun 2014
SPIWAY ENDONASAL ACCESS GUIDE
K132721 · Spiway, LLC · Jan 2014
MEDIENT MIDDLE TURBINATE IMPLANT
K130354 · Entrigue Surgical, Inc. · May 2013